메뉴 건너뛰기
Acta Oncologica
Volumn 45, Issue 5, 2006, Pages 625-626
Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients? [3]
Author keywords

[No Author keywords available]
Indexed keywords

ANTHRACYCLINE; CAPECITABINE; FLUOROURACIL; TAXANE DERIVATIVE;
EID: 33746776782     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600791509     Document Type: Letter
Times cited : (12)
References (5)
  • 1
    • 0033050165 scopus 로고    scopus 로고
    • Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
    • Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C, et al. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 1999;17:485-93.
    • (1999) J Clin Oncol , vol.17 , pp. 485-493
    • Blum, J.L.1    Jones, S.E.2    Buzdar, A.U.3    LoRusso, P.M.4    Kuter, I.5    Vogel, C.6
  • 2
    • 0035476911 scopus 로고    scopus 로고
    • Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast cancer patients
    • Blum JL, Dieras V, Lo Russo PM, Horton J, Rutman O, Buzdar A, et al. Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast cancer patients. Cancer 2001;92:1759-68.
    • (2001) Cancer , vol.92 , pp. 1759-1768
    • Blum, J.L.1    Dieras, V.2    Lo Russo, P.M.3    Horton, J.4    Rutman, O.5    Buzdar, A.6
  • 3
    • 10744229320 scopus 로고    scopus 로고
    • Multicentre, Phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    • Fumoleau P, Largillier R, Clippe C, Dieras V, Orfeuvre H, Lesimple T, et al. Multicentre, Phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Eur J Cancer 2004;40:536-42.
    • (2004) Eur J Cancer , vol.40 , pp. 536-542
    • Fumoleau, P.1    Largillier, R.2    Clippe, C.3    Dieras, V.4    Orfeuvre, H.5    Lesimple, T.6
  • 4
    • 0041508753 scopus 로고    scopus 로고
    • Multicenter phase II study of oral capecitabine (Xeloda®) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy
    • Reichardt P, Von Minckwitz G, Thuss-Patience PC, Jonat W, Kolbl H, Janicke F, et al. Multicenter phase II study of oral capecitabine (Xeloda®) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. Ann Oncol 2003;14:1227-33.
    • (2003) Ann Oncol , vol.14 , pp. 1227-1233
    • Reichardt, P.1    Von Minckwitz, G.2    Thuss-Patience, P.C.3    Jonat, W.4    Kolbl, H.5    Janicke, F.6
  • 5
    • 1842627763 scopus 로고    scopus 로고
    • Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer
    • Wist EA, Sommer HH, Ostenstad B, Risberg T, Bremnes Y, Mjaaland I. Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer. Acta Oncol 2004;43:186-9.
    • (2004) Acta Oncol , vol.43 , pp. 186-189
    • Wist, E.A.1    Sommer, H.H.2    Ostenstad, B.3    Risberg, T.4    Bremnes, Y.5    Mjaaland, I.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.